chartexchange

STOK
Stoke Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 19, 2026 2:41:41 PM EST
26.95USD+0.974%(+0.26)208,602
23.34Bid27.09Ask3.75Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Bedford, MA, USA
Previous Close
$26.69
Beta
1.00
52-Week High
$40.22 2026-03-10
52-Week Low
$22.05 2026-10-14
SMA 50
$26.25
SMA 200
$30.71
Avg. Vol 10D
814,551
Avg. Vol 30D
1.16M
Avg. Vol 90D
966,865
Relative Vol
0.18
46.50M
10,722,415
0.4000%
STOK Profile

stoke is developing antisense oligonucleotide medicines that target rna splicing to increase gene expression for the treatment of severe genetic diseases.

STOK Performance
PeriodPriceDateChangeBeta
1W26.202026-11-12+2.86%1.130
1M24.822026-10-19+8.58%1.208
3M33.032026-08-19-18.41%1.046
6M29.962026-05-19-10.05%0.865
1Y28.482025-11-19-5.37%1.000
2Y11.612024-11-19+132.13%—
5Y27.802021-11-19-3.06%1.343
STOK Stock Summary

Stoke Therapeutics, Inc. Common Stock (NASDAQ:STOK) stock price today is $26.95, and today's volume is 208,425. STOK is up 0.974% today. The 30 day average volume is 1.16M. STOK market cap is $1.76B with 65.41M shares outstanding.